Literature DB >> 17438213

Position statement on the coverage of anticonvulsant drugs for the treatment of epilepsy.

K Liow1, G L Barkley, J R Pollard, C L Harden, C W Bazil.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17438213     DOI： 10.1212/01.wnl.0000259400.30539.cc

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  32 in total

Review 1.  Update on anticonvulsant drugs.

Authors:  Derek J Chong; Carl W Bazil
Journal:  Curr Neurol Neurosci Rep       Date:  2010-07       Impact factor: 5.081

2.  Random-effects linear modeling and sample size tables for two special crossover designs of average bioequivalence studies: the four-period, two-sequence, two-formulation and six-period, three-sequence, three-formulation designs.

Authors:  Francisco J Diaz; Michel J Berg; Ron Krebill; Timothy Welty; Barry E Gidal; Rita Alloway; Michael Privitera
Journal:  Clin Pharmacokinet       Date:  2013-12       Impact factor: 6.447

3.  Epilepsy: Generic substitution: are antiepileptic drugs different?

Authors:  Carl W Bazil
Journal:  Nat Rev Neurol       Date:  2009-11       Impact factor: 42.937

4.  The backlash against bioequivalence and the interchangeability of brand-name and generic drugs.

Authors:  Aaron S Kesselheim
Journal:  CMAJ       Date:  2011-07-11       Impact factor: 8.262

5.  Evaluation of Switching Patterns in FDA's Sentinel System: A New Tool to Assess Generic Drugs.

Authors:  Joshua J Gagne; Jennifer R Popovic; Michael Nguyen; Sukhminder K Sandhu; Patty Greene; Rima Izem; Wenlei Jiang; Zhong Wang; Yueqin Zhao; Andrew B Petrone; Anita K Wagner; Sarah K Dutcher
Journal:  Drug Saf       Date:  2018-12       Impact factor: 5.606

6.  Generic antiepileptic drugs: current controversies and future directions.

Authors:  Michael D Privitera
Journal:  Epilepsy Curr       Date:  2008 Sep-Oct       Impact factor: 7.500

Review 7.  Bioequivalence of antiepileptic drugs: how close is close enough?

Authors:  Barry E Gidal
Journal:  Curr Neurol Neurosci Rep       Date:  2009-07       Impact factor: 5.081

8.  Seizure risk in brain tumor patients with conversion to generic levetiracetam.

Authors:  Terri S Armstrong; Shauna Choi; Julie Walker; Mark R Gilbert
Journal:  J Neurooncol       Date:  2009-11-21       Impact factor: 4.130

9.  Substitution of anticonvulsant drugs.

Authors:  Bernhard J Steinhoff; Uwe Runge; Otto W Witte; Hermann Stefan; Andreas Hufnagel; Thomas Mayer; Günter Krämer
Journal:  Ther Clin Risk Manag       Date:  2009-06-22       Impact factor: 2.423

Review 10.  Requirements for generic anti-epileptic medicines: a regulatory perspective.

Authors:  Marc Maliepaard; Yechiel A Hekster; Arnoud Kappelle; Eugène P van Puijenbroek; André J Elferink; Jan Welink; Christine C Gispen-de Wied; Frits J F Lekkerkerker
Journal:  J Neurol       Date:  2009-07-15       Impact factor: 4.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.